The Hoffmann Family of Companies, which invests in and in some cases manages a wide portfolio of assets, says it will seek a ...

Investors who purchased or acquired Fluence securities during the Class Period may, no later than MAY 12, 2025, seek to be appointed as a lead plaintiff representative of the class. To learn your ...

Eagle Pharmaceuticals, Inc. (OTCMKTS: EGRX) (the “Company” or “Eagle”) today announced that its Board of Directors (the “Board”) has approved an amendment to its previously disclosed limited duration ...

Workday, Inc. (NASDAQ: WDAY), the AI platform for managing people and money, today announced that its 2025 annual meeting of ...

Click here for more https://monteverdelaw.com/case/northstar-healthcare-income-inc-nhhs/. It is free and there is no cost or obligation to you. Keen Vision ...

Delaware legislators introduced proposed Senate Bill 21, providing for amendments to Sections 144 and 220 of the ...

Combined company expected to trade on Nasdaq under “KLRS” after closingPALO ALTO, Calif. and LEXINGTON, Mass., March 12, 2025 ...

AtlasClear Holdings, Inc. (“AtlasClear Holdings” or the “Company”) (NYSEAMEX: ATCH), plans to build a cutting-edge technology enabled financial servic ...

Faraday Future Intelligent Electric Inc. (NASDAQ: FFIE) (“Faraday Future,” “FF,” or the “Company”) today announced that all proposals presented at the ...

The open letter also provides context on the recent decision in the Delaware Court of Chancery (the “Court”) regarding the sharing of the Company’s confidential stockholder list. The open ...

Pliant Therapeutics, Inc. has announced the adoption of a limited duration stockholder rights agreement aimed at protecting shareholder interests in light of recent stock accumulations.

The Board remains fully aligned with stockholders in our mission to maximize value and provide a path toward stockholder liquidity. By contrast, non-stockholders Mike Cagney, his company Figure ...